Junhu Wan

2.0k total citations
46 papers, 1.3k citations indexed

About

Junhu Wan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Junhu Wan has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 28 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Junhu Wan's work include RNA modifications and cancer (30 papers), Cancer-related molecular mechanisms research (25 papers) and Cancer-related gene regulation (12 papers). Junhu Wan is often cited by papers focused on RNA modifications and cancer (30 papers), Cancer-related molecular mechanisms research (25 papers) and Cancer-related gene regulation (12 papers). Junhu Wan collaborates with scholars based in China and Ethiopia. Junhu Wan's co-authors include Jie Chu, Liang Ming, Fucheng He, Hongyang Liu, Huiqing Yin, Hongquan Zhang, Jun Zhan, Jinlin Jia, Lijun Yang and Jinxiu Sheng and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Oncogene.

In The Last Decade

Junhu Wan

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junhu Wan China 21 1.1k 740 167 159 91 46 1.3k
Shengni Hua China 16 829 0.8× 587 0.8× 253 1.5× 122 0.8× 65 0.7× 22 1.1k
Songbing He China 20 736 0.7× 519 0.7× 194 1.2× 112 0.7× 76 0.8× 34 957
Xiaoling Wu China 21 758 0.7× 543 0.7× 170 1.0× 83 0.5× 67 0.7× 54 996
Ziyou Lin China 10 1.3k 1.2× 825 1.1× 221 1.3× 284 1.8× 96 1.1× 15 1.6k
Yinu Wang United States 16 882 0.8× 617 0.8× 286 1.7× 209 1.3× 44 0.5× 26 1.2k
Dongling Zou China 16 994 0.9× 661 0.9× 184 1.1× 64 0.4× 57 0.6× 50 1.3k
Hongwei Li China 18 971 0.9× 888 1.2× 118 0.7× 57 0.4× 82 0.9× 50 1.2k
Yi Sang China 19 885 0.8× 433 0.6× 220 1.3× 108 0.7× 67 0.7× 44 1.1k

Countries citing papers authored by Junhu Wan

Since Specialization
Citations

This map shows the geographic impact of Junhu Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhu Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhu Wan more than expected).

Fields of papers citing papers by Junhu Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junhu Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhu Wan. The network helps show where Junhu Wan may publish in the future.

Co-authorship network of co-authors of Junhu Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Junhu Wan. A scholar is included among the top collaborators of Junhu Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junhu Wan. Junhu Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chang, Dan Du, Jie Yin, et al.. (2025). CircNF1 modulates the progression and immune evasion of esophageal squamous cell carcinoma through dual regulation of PD-L1. Cellular & Molecular Biology Letters. 30(1). 37–37. 5 indexed citations
2.
Xiao, Nan, Hongyang Liu, Li Yang, et al.. (2025). N-acetyltransferase 10 impedes EZH2/H3K27me3/GABARAP axis mediated autophagy and facilitates lung cancer tumorigenesis through enhancing SGK2 mRNA acetylation. International Journal of Biological Macromolecules. 297. 139823–139823. 6 indexed citations
3.
Xiao, Nan, et al.. (2024). Applications of single-cell analysis in immunotherapy for lung cancer: Current progress, new challenges and expectations. Journal of Advanced Research. 74. 269–281. 3 indexed citations
4.
Liu, Hongyang, Nan Xiao, Li Yang, et al.. (2024). RNA methylation‐related inhibitors: Biological basis and therapeutic potential for cancer therapy. Clinical and Translational Medicine. 14(4). e1644–e1644. 9 indexed citations
5.
Liu, Hongyang, et al.. (2023). Construction and Assessment of a Prognostic Risk Model for Cervical Cancer Based on Lactate Metabolism-Related lncRNAs. International Journal of General Medicine. Volume 16. 2943–2960. 1 indexed citations
6.
Wei, Jianwei, Li Wang, Yuyan Zhang, et al.. (2023). TRIM25 promotes temozolomide resistance in glioma by regulating oxidative stress and ferroptotic cell death via the ubiquitination of keap1. Oncogene. 42(26). 2103–2112. 19 indexed citations
7.
Chen, Youming, et al.. (2023). The functions and mechanisms of post-translational modification in protein regulators of RNA methylation: Current status and future perspectives. International Journal of Biological Macromolecules. 253(Pt 2). 126773–126773. 37 indexed citations
8.
Wan, Junhu, et al.. (2023). Ferroptosis-associated circular RNAs: Opportunities and challenges in the diagnosis and treatment of cancer. Frontiers in Cell and Developmental Biology. 11. 1160381–1160381. 10 indexed citations
9.
Guo, Huiling, Jianwei Wei, Yuyan Zhang, et al.. (2023). Protein ubiquitination in ovarian cancer immunotherapy: The progress and therapeutic strategy. Genes & Diseases. 11(6). 101158–101158. 4 indexed citations
10.
11.
Wan, Junhu, et al.. (2022). Long non‐coding RNA HOXC‐AS1 exerts its oncogenic effects in esophageal squamous cell carcinoma by interaction with IGF2BP2 to stabilize SIRT1 expression. Journal of Clinical Laboratory Analysis. 37(1). e24801–e24801. 10 indexed citations
12.
Wei, Jianwei, Zhengfeng Wang, Weiwei Wang, et al.. (2021). Oxidative Stress Activated by Sorafenib Alters the Temozolomide Sensitivity of Human Glioma Cells Through Autophagy and JAK2/STAT3-AIF Axis. Frontiers in Cell and Developmental Biology. 9. 660005–660005. 23 indexed citations
13.
Liu, Hongyang, et al.. (2021). Long non-coding RNA SOS1-IT1 promotes endometrial cancer progression by regulating hypoxia signaling pathway. Journal of Cell Communication and Signaling. 16(2). 253–270. 8 indexed citations
14.
Li, Hongle, Jinlin Jia, Lijun Yang, et al.. (2020). LncRNA MIR205HG Drives Esophageal Squamous Cell Carcinoma Progression by Regulating miR-214/SOX4 Axis. OncoTargets and Therapy. Volume 13. 13097–13109. 21 indexed citations
15.
Chu, Jie, Jinlin Jia, Lijun Yang, et al.. (2020). LncRNA MIR31HG functions as a ceRNA to regulate c-Met function by sponging miR-34a in esophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy. 128. 110313–110313. 20 indexed citations
16.
Liu, Hongyang, Junhu Wan, & Jie Chu. (2019). Long non-coding RNAs and endometrial cancer. Biomedicine & Pharmacotherapy. 119. 109396–109396. 54 indexed citations
17.
Yang, Lijun, Jie Chu, Jinlin Jia, et al.. (2019). <p>Long noncoding RNA FEZF1-AS1 promotes the motility of esophageal squamous cell carcinoma through Wnt/β-catenin pathway</p>. Cancer Management and Research. Volume 11. 4425–4435. 12 indexed citations
18.
Wan, Junhu, et al.. (2018). HOXB9 promotes endometrial cancer progression by targeting E2F3. Cell Death and Disease. 9(5). 509–509. 55 indexed citations
19.
Wan, Junhu, Lijun Yang, Jie Chu, et al.. (2018). The diagnostic value of long non-coding RNA MIR31HG and its role in esophageal squamous cell carcinoma. Life Sciences. 202. 124–130. 32 indexed citations
20.
Song, Jiagui, Weizhi Xu, Peng Wang, et al.. (2018). HOXB9 acetylation at K27 is responsible for its suppression of colon cancer progression. Cancer Letters. 426. 63–72. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shengni Hua Breakdown of academic impact, for papers by Songbing He Breakdown of academic impact, for papers by Xiaoling Wu Breakdown of academic impact, for papers by Ziyou Lin Breakdown of academic impact, for papers by Yinu Wang Breakdown of academic impact, for papers by Dongling Zou Breakdown of academic impact, for papers by Hongwei Li Breakdown of academic impact, for papers by Yi Sang
Rankless by CCL
2026